In a small clinical trial in Canada, a medicine commonly found in European cough syrups has shown early signs it might do ...

A decades-old cough medicine, Ambroxol, could be on the verge of a dramatic second act—not for sore throats, but for ...

Dementia poses a major health challenge with no safe, affordable treatments to slow its progression.

Today’s cough syrup could turn into tomorrow’s treatment for Parkinson’s disease. Recent research in the U.K. is the latest to suggest that a common ingredient in cough syrup, ambroxol, might be able ...

A COMMON cough medicine could help protect against dementia. A study found that it prevented people with Parkinson’s develop the memory-destroying disease. Around 145,000 people in the UK hav… ...

Researchers at Lawson Research Institute are studying Ambroxol - a common cough medicine in Europe - as a potential treatment for dementia linked to Parkinson’s disease LONDON, Ont. – Dementia ...

Dementia poses a major health challenge with no safe, affordable treatments to slow its progression. Researchers at Lawson Research Institute (Lawson), the research arm of St. Joseph's Health Care ...

Scientists hope the pharmacological data from this study could help conduct larger clinical trials to test the effectiveness of Ambroxol in slowing dementia symptoms.

London research: European cough medicine may aid Parkinson's patients Can a drug used for decades in Europe to treat the common cough be repurposed to slow or stop the progression of certain kinds ...

“We hope that Ambroxol, or drugs like Ambroxol, will be able to prevent the onset of Parkinson's disease and dementia if it is given early enough,” Dr Stephen Pasternak told The Standard.

A 12-month clinical trial investigated whether a cough medicine used in Europe called Ambroxol can slow dementia in people with Parkinson’s.